Showing results (71-80 of 629) with videos related to
Sort By:
Pageof 63
Best Practice & Research. Clinical Endocrinology & Metabolism|June 13, 2009
Aspirin and clopidogrel: efficacy and resistance in diabetes mellitusDominick J Angiolillo, Siva SuryadevaraNature Reviews. Cardiology|October 8, 2014
Novel antiplatelet agents in acute coronary syndromeFrancesco Franchi, Dominick J AngiolilloCirculation|October 13, 2016
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes MellitusDavide Capodanno, Dominick J AngiolilloJournal of Thrombosis and Thrombolysis|August 29, 2022
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover studyFrancesco Franchi, David J Schneider, Jayne Prats, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2023
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled studyFrancesco Franchi, Luis Ortega-Paz, Fabiana Rollini, et al.Expert Review of Clinical Pharmacology|January 6, 2026
The pharmacology and clinical evidence for the use of dual versus single antiplatelet therapyClaudio Laudani, Luis Ortega-Paz, Francesco Franchi, et al.Journal of Thrombosis and Thrombolysis|August 15, 2013
Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigationFabiana Rollini, Antonio Tello-Montoliu, Ronakkumar Patel, et al.Journal of Thrombosis and Thrombolysis|August 29, 2014
Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemmaJung Rae Cho, Dominick J AngiolilloAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 25, 2013
Antiplatelet and anticoagulant therapy for atherothrombotic disease: the role of current and emerging agentsDominick J Angiolillo, José Luis FerreiroAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 10, 2016
Clinical Pharmacology and Cardiovascular Safety of NaproxenDominick J Angiolillo, Steven M WeismanPageof 63